Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
{{output}}
Introduction: Previous research showed that the addition of bevacizumab (a monoclonal antibody against vascular endothelial growth factor [VEGF]) to chemotherapy resulted in a significant efficacy benefit in the treatment of sele... ...
